Treating erectile dysfunction after radical radiotherapy and androgen deprivation therapy (ADT) for prostate cancer

Prostate Cancer UK and Macmillan Cancer Support

Radiotherapy and androgen deprivation therapy for prostate cancer can induce structural changes in the penile tissue leading to delayed (for up to two years) or progressive erectile dysfunction. Erectile dysfunction (ED) affects up to 85% of men receiving ADT, and a similar number of men after radiotherapy. Early patient education and intervention is necessary to reduce the impact of ED on men and their partners.

This Guidelines summary covers assessment, predictive factors for recovery, and includes a useful treatment pathway.

Register to view this page

Log in or register now for FREE in order to:

  • benefit from unlimited access to all pages, including:
    • 180+ guideline summaries
    • 1000+ evidence-based articles
  • review and leave comments on all articles and summaries
  • automatically track your reading and learning via your CPD tracker
  • on-demand webinars presented by leading clinical experts

Registration only takes 2 minutes and it will give you FREE access to all content across:



Log in

Need help? Email us